Blood Pressure Associated with Arsenic Methylation and Arsenic Metabolism Caused by Chronic Exposure to Arsenic in Tube Well Water.

Bing Gan Wei; Bi Xiong YE; Jiang Ping YU; Lin Sheng Yang; Hai Rong LI; Ya Juan Xia; Ke Gong WU

Return

Blood Pressure Associated with Arsenic Methylation and Arsenic Metabolism Caused by Chronic Exposure to Arsenic in Tube Well Water.

Author: Bing Gan WEI ¹ ; Bi Xiong YE ² ; Jiang Ping YU ¹ ; Lin Sheng YANG ¹ ; Hai Rong LI ¹ ; Ya Juan XIA ³ ; Ke Gong WU ³
Author Information

1. Key Laboratory of Land Surface Pattern and Simulation, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China.
2. Institute of Environmental Health and Related Product Safety, Chinese Center for Disease Control and Prevention, Beijing 100021, China.
3. Inner Mongolia Center for Endemic Disease Control and Research, Huhhot 010031, Inner Mongolia, China.
Publication Type:Journal Article
Keywords: Arsenic; Arsenic metabolism; Arsenic methylation; Blood pressure; Drinking water
MeSH: Adult; Arsenic; analysis; metabolism; toxicity; Blood Pressure; drug effects; China; Drinking Water; analysis; chemistry; Environmental Exposure; Female; Humans; Male; Methylation; drug effects; Middle Aged; Water Pollutants, Chemical; analysis; toxicity; Young Adult
From: Biomedical and Environmental Sciences 2017;30(5):334-342
CountryChina
Language:English
Abstract:
OBJECTIVEThe effects of arsenic exposure from drinking water, arsenic metabolism, and arsenic methylation on blood pressure (BP) were observed in this study.
METHODSThe BP and arsenic species of 560 participants were determined. Logistic regression analysis was applied to estimate the odds ratios of BP associated with arsenic metabolites and arsenic methylation capability.
RESULTSBP was positively associated with cumulative arsenic exposure (CAE). Subjects with abnormal diastolic blood pressure (DBP), systolic blood pressure (SBP), and pulse pressure (PP) usually had higher urinary iAs (inorganic arsenic), MMA (monomethylated arsenic), DMA (dimethylated arsenic), and TAs (total arsenic) than subjects with normal DBP, SBP, and PP. The iAs%, MMA%, and DMA% differed slightly between subjects with abnormal BP and those with normal BP. The PMI and SMI were slightly higher in subjects with abnormal PP than in those with normal PP.
CONCLUSIONOur findings suggest that higher CAE may elevate BP. Males may have a higher risk of abnormal DBP, whereas females have a higher risk of abnormal SBP and PP. Higher urinary iAs may increase the risk of abnormal BP. Lower PMI may elevate the BP. However, higher SMI may increase the DBP and SBP, and lower SMI may elevate the PP.